Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Tumor Targeting with an isoDGR-Drug Conjugate.

Zanella S, Angerani S, Pina A, López Rivas P, Giannini C, Panzeri S, Arosio D, Caruso M, Gasparri F, Fraietta I, Albanese C, Marsiglio A, Pignataro L, Belvisi L, Piarulli U, Gennari C.

Chemistry. 2017 Jun 12;23(33):7910-7914. doi: 10.1002/chem.201701844. Epub 2017 May 26.

2.

Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.

Dal Corso A, Caruso M, Belvisi L, Arosio D, Piarulli U, Albanese C, Gasparri F, Marsiglio A, Sola F, Troiani S, Valsasina B, Pignataro L, Donati D, Gennari C.

Chemistry. 2015 Apr 27;21(18):6921-9. doi: 10.1002/chem.201500158. Epub 2015 Mar 17.

PMID:
25784522
3.

β-Blockers and cardiac protection.

Bolsin SN, Marsiglio A, Colson M.

Br J Anaesth. 2014 Oct;113(4):721-2. doi: 10.1093/bja/aeu288. No abstract available.

4.

Beta-blockade and noncardiac surgery.

Bolsin SN, Colson M, Marsiglio A.

J Cardiothorac Vasc Anesth. 2014 Jun;28(3):e25-6. doi: 10.1053/j.jvca.2014.01.013. Epub 2014 Mar 27. No abstract available.

PMID:
24685361
5.

Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.

Casuscelli F, Ardini E, Avanzi N, Casale E, Cervi G, D'Anello M, Donati D, Faiardi D, Ferguson RD, Fogliatto G, Galvani A, Marsiglio A, Mirizzi DG, Montemartini M, Orrenius C, Papeo G, Piutti C, Salom B, Felder ER.

Bioorg Med Chem. 2013 Dec 1;21(23):7364-80. doi: 10.1016/j.bmc.2013.09.054. Epub 2013 Oct 2.

PMID:
24139169
6.

Perioperative β blockade.

Bolsin S, Colson M, Marsiglio A.

BMJ. 2013 Sep 19;347:f5640. doi: 10.1136/bmj.f5640. No abstract available.

PMID:
24052587
7.

Bonding to dentin as a function of air-stream temperatures for solvent evaporation.

Marsiglio AA, Almeida JC, Hilgert LA, D'Alpino PH, Garcia FC.

Braz Oral Res. 2012 May-Jun;26(3):280-7.

8.

Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.

Bindi S, Fancelli D, Alli C, Berta D, Bertrand JA, Cameron AD, Cappella P, Carpinelli P, Cervi G, Croci V, D'Anello M, Forte B, Giorgini ML, Marsiglio A, Moll J, Pesenti E, Pittalà V, Pulici M, Riccardi-Sirtori F, Roletto F, Soncini C, Storici P, Varasi M, Volpi D, Zugnoni P, Vianello P.

Bioorg Med Chem. 2010 Oct 1;18(19):7113-20. doi: 10.1016/j.bmc.2010.07.048. Epub 2010 Jul 25.

PMID:
20817473
9.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.

Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, Croci V, Degrassi A, Texido G, Rocchetti M, Vianello P, Rusconi L, Storici P, Zugnoni P, Arrigoni C, Soncini C, Alli C, Patton V, Marsiglio A, Ballinari D, Pesenti E, Fancelli D, Moll J.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3158-68.

10.

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

Fancelli D, Moll J, Varasi M, Bravo R, Artico R, Berta D, Bindi S, Cameron A, Candiani I, Cappella P, Carpinelli P, Croci W, Forte B, Giorgini ML, Klapwijk J, Marsiglio A, Pesenti E, Rocchetti M, Roletto F, Severino D, Soncini C, Storici P, Tonani R, Zugnoni P, Vianello P.

J Med Chem. 2006 Nov 30;49(24):7247-51.

PMID:
17125279
11.

Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition.

Fancelli D, Berta D, Bindi S, Cameron A, Cappella P, Carpinelli P, Catana C, Forte B, Giordano P, Giorgini ML, Mantegani S, Marsiglio A, Meroni M, Moll J, Pittalà V, Roletto F, Severino D, Soncini C, Storici P, Tonani R, Varasi M, Vulpetti A, Vianello P.

J Med Chem. 2005 Apr 21;48(8):3080-4.

PMID:
15828847
12.

3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization.

Pevarello P, Brasca MG, Orsini P, Traquandi G, Longo A, Nesi M, Orzi F, Piutti C, Sansonna P, Varasi M, Cameron A, Vulpetti A, Roletto F, Alzani R, Ciomei M, Albanese C, Pastori W, Marsiglio A, Pesenti E, Fiorentini F, Bischoff JR, Mercurio C.

J Med Chem. 2005 Apr 21;48(8):2944-56. Erratum in: J Med Chem. 2005 Jul 28;48(15):5058.

PMID:
15828833
13.

Benzodipyrazoles: a new class of potent CDK2 inhibitors.

D'Alessio R, Bargiotti A, Metz S, Brasca MG, Cameron A, Ermoli A, Marsiglio A, Polucci P, Roletto F, Tibolla M, Vazquez ML, Vulpetti A, Pevarello P.

Bioorg Med Chem Lett. 2005 Mar 1;15(5):1315-9.

PMID:
15713378
14.

3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding.

Pevarello P, Brasca MG, Amici R, Orsini P, Traquandi G, Corti L, Piutti C, Sansonna P, Villa M, Pierce BS, Pulici M, Giordano P, Martina K, Fritzen EL, Nugent RA, Casale E, Cameron A, Ciomei M, Roletto F, Isacchi A, Fogliatto G, Pesenti E, Pastori W, Marsiglio A, Leach KL, Clare PM, Fiorentini F, Varasi M, Vulpetti A, Warpehoski MA.

J Med Chem. 2004 Jun 17;47(13):3367-80.

PMID:
15189033
15.

In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time.

Germani M, Magni P, De Nicolao G, Poggesi I, Marsiglio A, Ballinari D, Rocchetti M.

Cancer Chemother Pharmacol. 2003 Dec;52(6):507-13. Epub 2003 Aug 16.

PMID:
12923660
16.
17.

Antitumor activity of FCE 26644 a new growth-factor complexing molecule.

Sola F, Farao M, Pesenti E, Marsiglio A, Mongelli N, Grandi M.

Cancer Chemother Pharmacol. 1995;36(3):217-22.

PMID:
7781141
18.

Inhibition of lung and liver tumor colonies in mice pretreated with suramin.

Sola F, Farao M, Marsiglio A, Mariani M, Grandi M.

Invasion Metastasis. 1993;13(3):163-8.

PMID:
8112976
19.

Physical conditioning in the aging adult.

Marsiglio A, Holm K.

Nurse Pract. 1988 Sep;13(9):33-7, 41. Review.

PMID:
3050627

Supplemental Content

Loading ...
Support Center